Alessio Cortellini

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Mahvish Muzaffar

East Carolina University

UNITED STATES

View details

Mitchell Chen

Clinical Lecturer

Imperial College London

UNITED KINGDOM

View details

Georgina V. Long

University of Sydney

AUSTRALIA

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Maria Grazia Vitale

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Nicla La Verde

ITALY

View details

Chara Stavraka

NIHR Clinical Lecturer

King’s College London

UNITED KINGDOM

View details

Lorenza Rimassa

Humanitas University

ITALY

View details

Antonio D'Alessio

Imperial College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessio Cortellini

Research Interests

Explore related searches

Contact this professor

Articles (10)

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity from Programmed Cell Death-1 Pathway Inhibition in Non-Small Cell Lung Cancer

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.

Antibiotic Therapy: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer.

Safety of Extended interval Dosing Immune Checkpoint Inhibitors: a multicentre cohort study.

PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma.

Collaborators (9)

Mahvish Muzaffar

Mitchell Chen

Georgina V. Long

David J. Pinato

Maria Grazia Vitale

Nicla La Verde

Chara Stavraka

Lorenza Rimassa

Antonio D'Alessio

Make your next move.